TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32978722

Group type: EXPERIMENTAL
Intervention: 300 μg Buprenorphine Buccal Film (BBF)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 600 μg Buprenorphine Buccal Film (BBF)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 900 μg Buprenorphine Buccal Film (BBF)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 30 mg Oral Oxycodone
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 60 mg Oral Oxycodone
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 36198452

Group type: EXPERIMENTAL
Intervention: AVX001 gel 1%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: AVX001 gel 3%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 60
Study: 33361618

Group type: EXPERIMENTAL
Intervention: 10Hz over the ipsilesional primary motor cortex (M1) and next 1Hz over the contralesional M1
Number of subjects: 100

Group type: COMPARATOR
Intervention: Contralesional sham stimulation and next ipsilesional real 10Hz
Number of subjects: 100

Group type: COMPARATOR
Intervention: Contralesional real 1Hz rTMS and next ipsilesional sham stimulation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Bilateral sham-control procedures
Number of subjects: 100
Study: 32856605

Group type: EXPERIMENTAL
Intervention: Dutasteride
Number of subjects: 8122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8122
Study: 36364734

Group type: EXPERIMENTAL
Intervention: Oat product providing 3 g of β‐Glucan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rice control group
Number of subjects: 0
Study: 36189417

Group type: EXPERIMENTAL
Intervention: Evidence-based nursing education (12 sessions)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study: 32988954

Group type: EXPERIMENTAL
Intervention: Self-washing cloth masks by hand
Number of subjects: 607

Group type: COMPARATOR
Intervention: Cloth masks washed in hospital laundry
Number of subjects: 607

Group type: COMPARATOR
Intervention: Medical masks
Number of subjects: 607
Study: 35243636

Group type: EXPERIMENTAL
Intervention: Three quarters of a 20-mm diameter, 5-mm thick tablet
Number of subjects: 89
Study: 32735886

Group type: EXPERIMENTAL
Intervention: Flavin adenine dinucleotide (FAD)
Number of subjects: 0
Study: 34753412

Group type: EXPERIMENTAL
Intervention: betaxolol 0.5%
Number of subjects: 38

Group type: COMPARATOR
Intervention: brimonidine 0.2%
Number of subjects: 38
Study: 33640829

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (Laser irradiation using a GaAlAs diode laser at 810 nm, 27 J/cm2, 200 mW) applied on 12 points on malar area during 12 sessions within six weeks.
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Photobiomodulation (Laser irradiation)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no photobiomodulation treatment)
Number of subjects: 71
Study: 35172248

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Brief Adolescent Mindfulness (BAM)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Both MI and BAM
Number of subjects: 163
Study: 36330727

Group type: EXPERIMENTAL
Intervention: GrowEat project (nutrition intervention programme with home gardening activities); duration: 12 weeks.
Number of subjects: 134

Group type: COMPARATOR
Intervention: Control group (no intervention);
Number of subjects: 134
Study: 32321389

Group type: EXPERIMENTAL
Intervention: CIDT training
Number of subjects: 491

Group type: COMPARATOR
Intervention: Standard training
Number of subjects: 491
Study: 35965283

Group type: EXPERIMENTAL
Intervention: Text message reminders with embedded interactive educational information
Number of subjects: 2086

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2086
Study: 33413153

Group type: EXPERIMENTAL
Intervention: Montessori-based activities
Number of subjects: 108
Study: 32442355

Group type: EXPERIMENTAL
Intervention: Internet-delivered attention control therapy (ACT)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Treatment as usual in the community
Number of subjects: 119
Study: 35429294

Group type: EXPERIMENTAL
Intervention: FAST-B
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: FAST-NB
Number of subjects: 12

Group type: COMPARATOR
Intervention: CONV
Number of subjects: 12
Study: 34872550

Group type: EXPERIMENTAL
Intervention: Educational intervention based on integrated HBM with HL (e-learning through social media, 4 times during 4 weeks, educational booklets and pamphlets)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 140
Study: 33341828

Group type: EXPERIMENTAL
Intervention: Dynamic oscillatory stretch technique
Number of subjects: 83

Group type: COMPARATOR
Intervention: Static stretching technique
Number of subjects: 83
Study: 35236083

Group type: EXPERIMENTAL
Intervention: Primary cytoreduction in OC patients
Number of subjects: 220

Group type: COMPARATOR
Intervention: Primary cytoreduction in PPC patients
Number of subjects: 220

Group type: COMPARATOR
Intervention: Surgical complexity score
Number of subjects: 220

Group type: COMPARATOR
Intervention: Recurrence rates
Number of subjects: 220

Group type: COMPARATOR
Intervention: Progression-free survival (PFS)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Overall survival (OS)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Extraperitoneal disease and interval cytoreduction
Number of subjects: 220

Group type: COMPARATOR
Intervention: Suboptimal cytoreduction and delay in adjuvant chemotherapy
Number of subjects: 220
Study: 34844563

Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting prognosis of patients with CC
Number of subjects: 426
Study: 32321516

Group type: EXPERIMENTAL
Intervention: Nonimmersive VR games during exercise session
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (same exercises without VR games)
Number of subjects: 84
Study: 35305678

Group type: EXPERIMENTAL
Intervention: Reducing sitting time to no more than 4 hours per day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reducing sitting time by approximately 36 minutes per person per day in adults who sit 4 or more hours per day
Number of subjects: 0
Study: 33938830

Group type: EXPERIMENTAL
Intervention: 35 F DLT
Number of subjects: 50

Group type: COMPARATOR
Intervention: DLT based on height
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study: 32536316

Group type: EXPERIMENTAL
Intervention: Single-incision approach (group 1)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Dual-incision approach (group 2)
Number of subjects: 93
Study: 35426492

Group type: EXPERIMENTAL
Intervention: Nalmefene (18 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 34326035

Group type: EXPERIMENTAL
Intervention: Systemic treatment for SMZL
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Systemic treatment for NMZL
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Splenectomy for SMZL
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Histologic transformation (HT)
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Overall Survival (OS) for patients with HT
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Overall Survival (OS) for patients without HT
Number of subjects: 190

Group type: COMPARATOR
Intervention: Overall Survival (OS) comparison
Number of subjects: 190

Group type: COMPARATOR
Intervention: Time to First Systemic Treatment (TTFST)
Number of subjects: 190
Study: 35178225

Group type: EXPERIMENTAL
Intervention: Information technology for care management
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional care methods
Number of subjects: 104
Study: 33743237

Group type: EXPERIMENTAL
Intervention: Second intravenous immunoglobulin dose (SID) 2 g/kg over 5 days
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 32845800

Group type: EXPERIMENTAL
Intervention: Intervention group (n=51) completed questionnaires and participated in interventions to increase mortality awareness
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (n=47) only completed the questionnaires
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intervention group (n=51)
Number of subjects: 98
Study: 32342840

Group type: EXPERIMENTAL
Intervention: Azithromycin mass drug administration (MDA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35761105

Group type: EXPERIMENTAL
Intervention: Same Days (SD) - Resistance training followed by HIIT
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Different Days (DD) - Resistance training on specific days and HIIT on alternate days
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control - Treatment as usual
Number of subjects: 21
Study: 34429614

Group type: EXPERIMENTAL
Intervention: SCIT+dupilumab (300 mg every 2 weeks)
Number of subjects: 103

Group type: COMPARATOR
Intervention: SCIT alone
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: SCIT+dupilumab
Number of subjects: 103
Study: 32944278

Group type: EXPERIMENTAL
Intervention: Therapist-led manoeuvres
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Patient-led exercises
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Advice
Number of subjects: 75

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 75
Study: 34911042

Group type: EXPERIMENTAL
Intervention: Mothers and Daughters Moving Together intervention
Number of subjects: 31

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 31
Study: 36217830

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention emphasizing belief disconfirmation (CbI)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Behavioral intervention emphasizing exposure (BI)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 59
Study: 33881530

Group type: EXPERIMENTAL
Intervention: Sodium benzoate (250 to 1500 mg/d)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 97
Study: 36294478

Group type: EXPERIMENTAL
Intervention: HT‐PTI
Number of subjects: 45

Group type: COMPARATOR
Intervention: FHT
Number of subjects: 45
Study: 34050261

Group type: EXPERIMENTAL
Intervention: Ionising radiation exposure (mean ABM dose 0.14 Gy)
Number of subjects: 143136

Group type: EXPERIMENTAL
Intervention: Ionising radiation exposure
Number of subjects: 143136
Study: 32307658

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I) including sleep hygiene information, stimulus control, sleep restriction, and bedtime imagery audio recording.
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group with similar interventions but without sleep restriction and using audio recordings of bedtime short stories.
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 93
Study: 33855642

Group type: EXPERIMENTAL
Intervention: True acupressure (TAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sham acupressure (SAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enhanced standard care (ESC)
Number of subjects: 0
Study: 33248986

Group type: EXPERIMENTAL
Intervention: Cimlanod 6 μg/kg/min
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Cimlanod 12 μg/kg/min
Number of subjects: 322

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Cimlanod
Number of subjects: 322
Study: 36245835

Group type: EXPERIMENTAL
Intervention: Catgut embedding plus warm needle moxibustion
Number of subjects: 120

Group type: COMPARATOR
Intervention: Diclofenac sodium sustained-release tablet (100 mg) once a day for 8 courses (7 days each course)
Number of subjects: 120
Study: 35110346

Group type: EXPERIMENTAL
Intervention: Peer-assisted learning (PAL)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Expert-assisted learning (EAL)
Number of subjects: 166
Study: 34095297

Group type: EXPERIMENTAL
Intervention: Nomogram based on smoking status, waist circumference, hemoglobin A1c, and fasting blood glucose
Number of subjects: 2741
Study: 33034564

Group type: EXPERIMENTAL
Intervention: App with personalized coaching
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: App only
Number of subjects: 129
Study: 35665288

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate combined with labetalol
Number of subjects: 500

Group type: COMPARATOR
Intervention: Conventional magnesium sulfate
Number of subjects: 500
Study: 36014905

Group type: EXPERIMENTAL
Intervention: Egg consumption
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (no egg consumption)
Number of subjects: 155
Study: 34462343

Group type: EXPERIMENTAL
Intervention: CC with telemedicine
Number of subjects: 422

Group type: COMPARATOR
Intervention: CC alone
Number of subjects: 422
Study: 35439246

Group type: EXPERIMENTAL
Intervention: P2S program (intervention group, n = 199; 28 lost at follow-up)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: P2S program (intervention group)
Number of subjects: 399

Group type: COMPARATOR
Intervention: Generic health websites (control group, n = 200; 15 lost at follow-up)
Number of subjects: 399
Study: 32761487

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise (BE) for 12 weeks
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual physical exercise (control group) for 12 weeks
Number of subjects: 110
Study: 34419082

Group type: EXPERIMENTAL
Intervention: MitoQ (20 mg·day−1)
Number of subjects: 19
Study: 33022148

Group type: EXPERIMENTAL
Intervention: Vocal music listening
Number of subjects: 83

Group type: COMPARATOR
Intervention: Instrumental music
Number of subjects: 83

Group type: COMPARATOR
Intervention: Audiobooks
Number of subjects: 83
Study: 35467228

Group type: EXPERIMENTAL
Intervention: Internet-based motivational interviewing sessions (5 weekly sessions)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Internet-based motivational interviewing
Number of subjects: 100
Study: 34493319

Group type: EXPERIMENTAL
Intervention: liso-cel
Number of subjects: 256
Study: 33502473

Group type: EXPERIMENTAL
Intervention: Standard therapy (ST) plus belimumab 10 mg/kg
Number of subjects: 1684

Group type: COMPARATOR
Intervention: Standard therapy (ST) alone
Number of subjects: 1684

Group type: EXPERIMENTAL
Intervention: SRI-4 responders
Number of subjects: 1684

Group type: COMPARATOR
Intervention: SRI-4 non-responders
Number of subjects: 1684

Group type: EXPERIMENTAL
Intervention: Add-on belimumab 10 mg/kg in antimalarial users
Number of subjects: 1684

Group type: EXPERIMENTAL
Intervention: Add-on belimumab 10 mg/kg in anti-dsDNA positive patients
Number of subjects: 1684

Group type: EXPERIMENTAL
Intervention: Add-on belimumab 10 mg/kg in anti-Sm positive patients
Number of subjects: 1684
Study: 32075307

Group type: EXPERIMENTAL
Intervention: Modified OTAGO Exercise Program (8 weeks, 3 times a week)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Regular activities (Control Group)
Number of subjects: 34
Study: 33621815

Group type: EXPERIMENTAL
Intervention: Self-management intervention (SMI) including routine monthly counseling, individual face-to-face health counseling (1 h/month), and remote counseling (at least twice per month).
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group (CG) received routine monthly counseling.
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Self-management intervention (SMI) for participants with seizure frequency of ≥1 per year.
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Self-management intervention (SMI) for participants with seizure frequency of <1 per year.
Number of subjects: 155

Group type: COMPARATOR
Intervention: Self-management intervention (SMI) and control group (CG) comparison.
Number of subjects: 155
Study: 35305347

Group type: EXPERIMENTAL
Intervention: Intramuscular 10 units (IM group)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Intravenous 10 units in 100 ml 0.9% NaCl solution over 10-15 min (IV group)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Combined IV + IM regimens (IV + IM group)
Number of subjects: 210
Study: 33982512

Group type: EXPERIMENTAL
Intervention: Classic TCM prescriptions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled evidence-based studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical registration studies
Number of subjects: 0
Study: 35472696

Group type: EXPERIMENTAL
Intervention: Expectancy Challenge Alcohol Literacy Curriculum (ECALC)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Attention-matched control presentation
Number of subjects: 48
Study: 33223020

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (SRS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Boost SRS after fractionated radiation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bevacizumab with SRS
Number of subjects: 0
Study: 33406064

Group type: EXPERIMENTAL
Intervention: Surgical cytoreduction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Platinum/taxane‐based chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimally invasive cytoreductive procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intraoperative heated intraperitoneal chemotherapy
Number of subjects: 0
Study: 34802253

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study: 33272675

Group type: EXPERIMENTAL
Intervention: Supervised machine learning virtual screening procedure
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: In vitro and in vivo assays of selected pesticides
Number of subjects: 777

Group type: EXPERIMENTAL
Intervention: Screening of pesticides for AhR activity
Number of subjects: 777
Study: 33196806

Group type: EXPERIMENTAL
Intervention: Balanced crystalloids (clinician's choice of Ringer lactate solution or Plasma‐Lyte A solution)
Number of subjects: 172

Group type: COMPARATOR
Intervention: Saline (0.9% sodium chloride)
Number of subjects: 172
Study: 34374114

Group type: EXPERIMENTAL
Intervention: MB02 (3 mg/kg intravenous dose)
Number of subjects: 114

Group type: COMPARATOR
Intervention: US-bevacizumab (3 mg/kg intravenous dose)
Number of subjects: 114

Group type: COMPARATOR
Intervention: EU-bevacizumab (3 mg/kg intravenous dose)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: All treatments (MB02, US-bevacizumab, EU-bevacizumab)
Number of subjects: 114
Study: 34086595

Group type: EXPERIMENTAL
Intervention: Ostomy Self-management Telehealth (OSMT) intervention
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Telehealth engineering support
Number of subjects: 93
Study: 36163694

Group type: EXPERIMENTAL
Intervention: Weekly home-based physiotherapy for 12 weeks facilitating 100 minutes/week of moderate-intensity walking
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 38
Study: 33439309

Group type: EXPERIMENTAL
Intervention: Self-reported moderate-to-vigorous physical activity
Number of subjects: 377234

Group type: EXPERIMENTAL
Intervention: Self-reported vigorous physical activity
Number of subjects: 377234

Group type: EXPERIMENTAL
Intervention: Overall acceleration average
Number of subjects: 377234

Group type: EXPERIMENTAL
Intervention: Fraction of accelerations
Number of subjects: 377234
Study: 33332189

Group type: EXPERIMENTAL
Intervention: Total body irradiation (TBI) plus etoposide
Number of subjects: 417

Group type: COMPARATOR
Intervention: Chemoconditioning (fludarabine, thiotepa, and either busulfan or treosulfan)
Number of subjects: 417

Group type: EXPERIMENTAL
Intervention: Total body irradiation (TBI)
Number of subjects: 417
Study: 33059741

Group type: EXPERIMENTAL
Intervention: Shared follow-up care intervention (EMINENT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual, specialist-led, follow-up care
Number of subjects: 60
Study: 35045416

Group type: COMPARATOR
Intervention: Everolimus (EVE)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Axitinib (TKI)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both EVE and TKI
Number of subjects: 22
Study: 34472897

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI) technical skills
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Complex reflections in MI
Number of subjects: 179
Study: 32782254

Group type: EXPERIMENTAL
Intervention: Queens choosing between two empty nesting chambers; no specific dosage or duration mentioned.
Number of subjects: 0
Study: 36147577

Group type: EXPERIMENTAL
Intervention: CANA/MET (CANA 100 mg once daily plus MET 1000 mg twice daily)
Number of subjects: 51

Group type: COMPARATOR
Intervention: MET (MET 1000 mg twice daily)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: CANA/MET
Number of subjects: 51

Group type: COMPARATOR
Intervention: MET
Number of subjects: 51
Study: 33077301

Group type: EXPERIMENTAL
Intervention: Liq PCV‐free HRV
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Lyo HRV
Number of subjects: 1272
Study: 33158396

Group type: EXPERIMENTAL
Intervention: Micro expression training software
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 55
Study: 35575053

Group type: EXPERIMENTAL
Intervention: Creative expression program (CrExp, n = 18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (CG, n = 18)
Number of subjects: 36
Study: 33287713

Group type: EXPERIMENTAL
Intervention: Standard anti-TB treatment
Number of subjects: 80
Study: 35473643

Group type: EXPERIMENTAL
Intervention: Community participation in the planning and implementation of the Trial
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Community participation skills training and support
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Long process of relationship building between stakeholders
Number of subjects: 173
Study: 33775499

Group type: EXPERIMENTAL
Intervention: Physician self-disclosure
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Physician self-disclosure (female physicians)
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Physician self-disclosure (male physicians)
Number of subjects: 244
Study: 35811716

Group type: EXPERIMENTAL
Intervention: Algorithm based on the pCO2 gap and P(v–a)CO2/C(a–v)O2 ratio
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual clinical practice
Number of subjects: 180
Study: 32112730

Group type: EXPERIMENTAL
Intervention: Prelabor screening test combining cerebroplacental ratio and maternal placental growth factor
Number of subjects: 501

Group type: COMPARATOR
Intervention: Routine obstetric care (Control)
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Screen-positive women
Number of subjects: 501